AESTHETICS
AESTHETICS
Mx Aesthetics is a beauty clinic focused on helping clients achieve ageless beauty through simple and effective procedures.
Offering streamlined regimens to address issues like fine lines, wrinkles, volume loss, and improve skin quality.
We offer a simple treatments that I myself personally use to maintain my ageless beauty.
Jeuveau® is an FDA-approved injectable treatment specifically designed to reduce moderate to severe frown lines. It offers a smooth, youthful appearance with quick results and minimal downtime, making it a modern, effective option for wrinkle reduction.
$12 unit / $900 vial
Revanesse, a premium dermal filler designed to enhance facial volume and smooth fine lines, providing a natural and refreshed look. With its unique, smooth formula, Revanesse integrates seamlessly into the skin, offering long-lasting results with minimal swelling and downtime.
$650 Syringe
With SkinPen, loving the skin you’re in is easier than ever. Trusted by top healthcare providers, this FDA-cleared device is crafted with an unmatched focus on safety and effectiveness, offering a customized, inside-out rejuvenation for youthful-looking skin.
Face $300
Face and Neck $350
Interested in combating aging with Jeuveau®? This neurotoxin offers temporary wrinkle-reducing, targeting mild to severe lines on the forehead, between brows, and even delicate crow’s feet. Jeuveau® can also effectively diminishes bunny lines over the bridge of the nose and marionette lines around the mouth’s corners.
What is Jeaveau? Jeuveau® is an injectable anti-aging treatment that’s used in a similar fashion to Botox®. Also derived from botulinum toxin type A, this effective neurotoxin has been dubbed the New Botox — or “Newtox.” It is touted as having a higher degree of purity compared to Botox and is known for its fast onset of action.
Smooth out wrinkles
Prevent new formation of wrinkle.
You’re in charge of your own beauty.
You know exactly what you want
You want to look refreshed, not overdone.
You want to look flexible not frozen. You want to look like you. Unapologetically Beautiful on your terms. With Jeaveau. You want Jeuveau by Evolus, a modern-made tox designed to achieve fast-acting, natural-looking results starting in as little as 2 days.*
SkinPen® Precision
Microneedling procedures are performed in a minimally-invasive (little to no introduction of the instrument into the body) and precise manner with the use of the sterile needle head. The procedure is normally completed within 30–60 minutes, depending on the required procedure and anatomical site.
What is MicroNeedling? (Skin Pen) SkinPen creates micro-channels (microscopic holes) at a rate of 1600 per second. These wounds stimulate your skin, kicking its healing process into high gear. Best of all, SkinPen doesn’t rely on heat or chemicals, so the results are natural and safe for all skin tones and types.
Inflammation
SkinPen’s microneedles penetrate the skin’s surface, triggering a natural immune response to disinfect, remove debris, increase blood flow, and activate the creation of new tissue.
Proliferation
The micro-channels or tiny holes created by SkinPen are rebuilt with new granulation cells that include collagen proteins. Additionally, a new network of blood vessels develops.
Remodeling
New dermal tissues form, rich in collagen and elastin proteins. These proteins improve skin quality, visibly reducing facial acne scars and neck wrinkles, leaving skin more smooth, radiant, and younger-looking.
Pre-treatment
Avoid sun exposure and sunburns for 24 hours before treatment. You should also stop using retinol products, alpha hydroxy acids (AHAs), beta hydroxy acids, vitamin C, and other skincare products like cleansers, moisturizers, and sunblocks 24 hours before treatment. If you take ibuprofen (Motrin, Advil) or other NSAIDs like aspirin or naproxen, you should stop taking them three days before treatment. You should also remove any self-tanner from the treated area.
Post-treatment
Immediately after treatment, your skin may feel warm and tighter than usual, and look like it has a moderate to severe sunburn. For the first 6–8 hours, you should avoid touching, washing, or applying anything to the treated skin, including makeup, SPF, or other products. You should also avoid wearing clothing, headbands, hats, or scarves over the treated area, and if you do wear clothing, it should be cotton and not treated with fabric softeners or dryer sheets.
Revanesse is a line of injectable dermal fillers made with hyaluronic acid, a naturally occurring substance in the skin that provides moisture, volume, and elasticity. Known for its smooth consistency and natural-looking results, Revanesse is a popular choice for patients seeking subtle enhancements to their facial contours, hydration, and overall skin appearance. The line includes different formulations tailored to specific areas of the face, allowing it to address concerns like fine lines, wrinkles, and volume loss in areas such as the cheeks, lips, and nasolabial folds.
One of Revanesse’s unique attributes is its proprietary Thixofix® cross-linking technology, which enhances the durability and cohesiveness of the hyaluronic acid gel. This process allows the filler to integrate seamlessly into the skin, providing natural-looking results that can last from six months to a year, depending on the product used and individual skin characteristics. Revanesse’s composition is designed to reduce swelling and minimize downtime compared to other fillers, making it an appealing option for those looking for quick recovery.
Revanesse is commonly used by aesthetic professionals because it provides a balance of volume and flexibility, adapting well to facial expressions while maintaining the desired enhancement. Its versatility means it’s effective for both subtle lip augmentation and more substantial facial contouring. Revanesse is FDA-approved and extensively tested, with a safety profile that ensures both effective and safe treatments for patients seeking non-surgical facial rejuvenation.
Biojuve is a skincare brand that uses living microbe technology to support the skin’s microbiome and improve its health. The brand’s products are designed to work together to enhance the performance of Xycrobe technology, which is a combination of proteins, fatty acids, polypeptides, and antioxidants. Xycrobe technology targets specific skin conditions using a live strain of skin-relevant bacteria called Cutibacterium acnes subspecies defendens (C. acnes defendens).
Biojuve Living Biome Essential Serum – Experience the leading edge of skin science: a smooth rejuvenating formula that hosts Xycrobes technology. This living microbe technology is a breakthrough solution that enhances the skin’s microbiome ans optimizes skin health for better, younger-looking skin. These clinically-proven products were designed to improve the appearance of coarse wrinkles, fine lines, texture, tone, photo damage and overall dull, lackluster complexion.
This formula continually produce and delivers potent bio-essentials such as proteins, fatty acid, polypeptides and antioxidants around the clock for impactful results you can see and feels as your skin achieves it’s full potential.
Biojuve Conditioning Cleanse- Lift away dirt and impurities while keeping skin naturally balanced and well-conditioned as this innovated Conditioning Cleanse helps preserve and promote a thriving microbiome for optimal skin health.
This twice- daily cleanse helps support the living microbe technology found in the Living biome Essential’s serum.
Biojuve Support Complex- Helps optimize skin health and restore natural radiance with this supplemental, extracted blend of microbe-derived proteins, polypeptides, antioxidants and more.
Better Together: Support the performance of the living microbe technology found in the Living Biome Essential Serum by giving skin’s beneficial functions a boost each morning.
Biojuve Sheer Finish Sunscreen: UVA/UVB Protection Broad Spectrum SPF 50 (Water Resistant 80 Minutes). This Ultra-light sunscreen is designed with health of your skin’s microbiome in mind. Smooth to apply, this elegant, mineral formula quickly dries clear for sheer UVA and UVB protection. And the it goes the extra mile- a super-blend of hydrating hyaluronic acid, antioxidants, vitamin E and shea butter help nourish and moisturize skin while a combination of plant extracts helps protect skin from damaging blue light.
Rejuran Skin Care:
About c-PDRN
c-PDRN is a patented, marine based DNA growth factor (Hydrolyzed DNA) which helps increase cellular turnover and improve the appearance of elasticity while restoring the look of skin firmness.
More than 7 organic ingredients provides rich antioxidants, moisturizing, skin nutrition and soothing effects
Rejuran MEDI Heaing Care Set
Rejuran MEDI Line, developed by leading Korean skin and cosmetics experts and now available in the U.S. utilizes the propriety skin-healing ingredients c-PDRN along select organic raw materials. Our revolutionary cosmetics support natural healing and skin turnover, helping to minimize the appearance of aging.
Advance Line
Healer Line:
Healer Rebalancing Toner – Refresh and Rebalance your complexion with this hydrating toner formulated witj antibacterial Tea Tree Leaf extract, exfoliating PHAs, and skein soothing c-PDRN. Gently purifies skin of oil, residue, and dead skin cells. Skin will appear smoother, more hydrated, and healthier-looking skin. (120ml/ 4 oz.)
Healer Turnover Ampoule
Healer Nutritive Cream
Healer Healing Mask – Skin mat be damaged by envormental factors, harsh treatments, or peels. This concentrated microfiber sheet mask delivers nurturing and soothing actives to calm irritated skin and support its natural healing process. It is formulated with calming Aloe Vera, Adenosine, and patented Rejuran powerhouse, c-PDRN.
Advance Line –
Advance anti-agining retinol + c-PDRN-
Advance Intensive Pigment Corrector
Advance Active Night Repair Eye Cream
Advance Face & Neck Firming Cream
Advance Calming & Soothing Cleanser
Addition to microblading treatment
What is Healing Essence with 2% Hydrolyzed DNA (PN)? It’s the latest innovation from South Korea and is formulated wth 2% Hydrolyzed DNA (PN) for skin rejuvenation. It is delivered into the dermis to support skin’s natural growth factors, thus promoting cellural turnover and collagen production, improving microcirculation and inti-inflammation. Rehydrates severely dry skin and improves skin’s natural barrier for more luminous translucent-looking skin.
10 Benefits:
What to expect after treatment:
Purpose: helps support natural cell regeneration while deeply hydration promotes a healthier-looking complextion
DNA fragments extracted from wild salmon made possible by PharmaResearch’s patented technology, DOT.
Clear, colorless viscous solution
Long lasting while maintaining uniform structure in tissue
Proven to be the most compatible to human skin without causing any adverse effects
Stimulating skin’s own reparative and restorative capabilities
Skin elasticity improvement by recovering the biological condition of the dermis and epidermis.
Rejuran Skin Booster:
Contains: 1% Hydrolyzed DNA (PDRN), Hyaluronic Acid, 4 types of amino acids (Glycine, L-Lysine, L-Leucine, L-Proline)
Benefits:
Support natural cellular regeneration
Provides nutrients essential for collagen production and retains moisture
Gives skin a more elastic look & reduces the appearance of wrinkles
4 Amino Acids helps skin recover from oxidative stress
Purpose: Reinforce skin’s own barrier function and helps boost collagen production.
Rejuran Tone-Up Booster:
Formulated with powerful cocktails of clinically-proven active ingredients – including 1% Hydrolyzed DNA (PDRN), Hyaluronic Acid, Ascorbic Acid, and Tranexamic Acid – this dual- action treatment simultaneously evens skin’s coloration and rejuvenates dry, dull skin from the inside out. The result: a brighter, smoother, and more hydrated complexion.
Purpose: Brightens and revives skin while supporting natural collagen production.
*** Tranexamic Acid – a whiting agent that can reduce the skin’s sensitivity to UV radiation and stop chemical pathways to cause pigmentation.
*** Glutathione – When combined with tranexamic acid, Glutathione can help lighten pigmentation and even and brighten skin tone.
IMPORTANT SAFETY INFORMATION FOR JEUVEAU® (prabotulinumtoxinA-xvfs)
WARNING: DISTANT SPREAD OF TOXIN EFFECT: The effects of all botulinum toxin products, including JEUVEAU, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. JEUVEAU is not approved for the treatment of spasticity or any conditions other than glabellar lines.
CONTRAINDICATIONS
JEUVEAU is contraindicated in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site(s).
WARNINGS AND PRECAUTIONS
Spread of Toxin Effect
Postmarketing safety data from other approved botulinum toxins suggest that botulinum toxin effects may be observed beyond the site of local injection. The symptoms are consistent with the mechanism of action of botulinum toxin and may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, blurred vision and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death related to spread of toxin effects. In unapproved uses, including upper limb spasticity in children and approved indications, symptoms consistent with spread of toxin effect have been reported at doses comparable to or lower than the maximum recommended total dose. JEUVEAU is not approved for the treatment of spasticity or any conditions other than glabellar lines. Patients or caregivers should be advised to seek immediate medical care if swallowing, speech or respiratory difficulties occur.
Lack of Interchangeability between Botulinum Toxin Products
The potency Units of JEUVEAU are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of JEUVEAU cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.
Serious Adverse Reactions with Unapproved Use
Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received botulinum toxin injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of botulinum toxin products to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of botulinum toxin products.
Hypersensitivity Reactions
Serious and/or immediate hypersensitivity reactions have been reported for botulinum toxin products, including anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur with JEUVEAU, discontinue use of JEUVEAU and immediately institute appropriate medical therapy.
Cardiovascular System
There have been reports following administration of botulinum toxins of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.
Increased Risk of Clinically Significant Effects with Pre-existing Neuromuscular Disorders
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (e.g., myasthenia gravis or Lambert-Eaton syndrome) were excluded from the JEUVEAU clinical studies. Patients with neuromuscular disorders may be at increased risk of clinically significant effects, including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia and respiratory compromise from typical doses of JEUVEAU.
Dysphagia and Breathing Difficulties
Treatment with botulinum toxin products, including JEUVEAU, can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing.
Deaths as a complication of severe dysphagia have been reported after treatment with botulinum toxin. Dysphagia may persist for several months, and require use of a feeding tube to maintain adequate nutrition and hydration. Aspiration may result from severe dysphagia and is a particular risk when treating patients in whom swallowing or respiratory function is already compromised.
Patients treated with botulinum toxin products, including JEUVEAU, may require immediate medical attention should they develop problems with swallowing, speech or breathing.
Pre-existing Conditions at the Injection Site
Caution should be used when JEUVEAU is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s). Caution should be used when JEUVEAU treatment is used in patients who have marked facial asymmetry, ptosis, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin or when subjects do not respond to 20 Units of botulinum toxin (e.g. the inability to substantially lessen glabellar lines even by physically spreading them apart). Do not exceed the recommended dosage and frequency of administration of JEUVEAU.
Ophthalmic Adverse Reactions in Patients Treated with Botulinum Toxin Products
Dry eye has been reported with the use of botulinum toxin products in the treatment of glabellar lines. Reduced tear production, reduced blinking, and corneal disorders, may occur with use of botulinum toxins, including JEUVEAU. If symptoms of dry eye (e.g., eye irritation, photophobia, or visual changes) persist, consider referring patient to an ophthalmologist.
Human Albumin and Transmission of Viral Diseases
JEUVEAU contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases. A theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD) is also considered extremely remote. No cases of transmission of viral diseases or CJD have ever been reported for albumin.
ADVERSE REACTIONS
The most frequently reported adverse reactions (≥ 1% and placebo) following injection of JEUVEAU were headache (12%), eyelid ptosis (2%), upper respiratory tract infection (3%), and white blood cell count increase (1%).
DRUG INTERACTIONS
No formal drug interaction studies have been conducted with JEUVEAU. The potential for certain drugs to potentiate the effects of JEUVEAU warrant consideration given the potential risks involved and should be used with caution, including: aminoglycosides or other agents interfering with neuromuscular transmission, anticholinergic drugs, botulinum neurotoxin products, and muscle relaxants.
USE IN SPECIFIC POPULATIONS
The limited available data on JEUVEAU use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes.
There are no data on the presence of JEUVEAU in human or animal milk, its effects on the breastfed infant, or its effects on milk production.
Safety and effectiveness in pediatric patients have not been established.
INDICATION
JEUVEAU is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
Please note that this information is not comprehensive. For more information about JEUVEAU, see the full Prescribing Information including BOXED WARNING, and Medication Guide.
AESTHETICS